Literature DB >> 11111362

Consumers' willingness to pay for pharmacy services that reduce risk of medication-related problems.

D C Suh1.   

Abstract

OBJECTIVE: To measure willingness to pay (WTP) for pharmacists' services directed toward reducing the risk of medication-related problems and to determine factors that have a significant influence on WTP.
DESIGN: WTP was measured using a contingent valuation method that involved asking respondents about their maximum WTP for pharmacists' services using a self-administered questionnaire. Respondents' WTP through ex post (out of pocket) and ex ante (insurance premium) methods were measured using three hypothetical scenarios illustrating reductions in the risk of medication-related problems. Logistic regression and semilog regression were performed to evaluate the responses to the survey.
SETTING: Outpatient clinic of Robert Wood Johnson University Hospital and two physician offices located in New Jersey. PARTICIPANTS: A convenience sample of 316 patients and/or family members, who visited the study site between March 1 and September 15, 1999, were included. MAIN OUTCOME MEASURES: Amounts patients were willing to pay out of pocket or through insurance premiums for pharmacists' services.
RESULTS: The mean WTP out of pocket for pharmacy services ranged from $4.02 to $5.48 per prescription, depending on the level of risk reduction. Mean WTP through an increased insurance premium ranged from $28.79 to $36.29 per year. Overall, the average WTP for a pharmacist's consultation was $5.57, and WTP increased by $0.87 as counseling time increased by 1 minute. WTP was sensitive to changes in the magnitude of risk reduction in both ex post and ex ante scenarios. Income was positively related to WTP, but not to the level of statistical significance.
CONCLUSION: Respondents were willing to pay for pharmacists' services that reduce the risk of medication-related problems. Additional investigations to determine the factors that influence WTP for health care professionals' services are warranted.

Entities:  

Mesh:

Year:  2000        PMID: 11111362     DOI: 10.1016/s1086-5802(16)31129-9

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  7 in total

1.  Contingent valuation and pharmacists' acceptable levels of compensation for medication therapy management services.

Authors:  Junling Wang; Song Hee Hong
Journal:  Res Social Adm Pharm       Date:  2012-03-20

2.  Patient satisfaction with a chronic kidney disease risk assessment service in community pharmacies.

Authors:  Pankti A Gheewala; Gregory M Peterson; Syed Tabish R Zaidi; Matthew D Jose; Ronald L Castelino
Journal:  Int J Clin Pharm       Date:  2018-02-13

3.  Willingness to pay for a pharmacist's dispensing service: a cross-sectional pilot study in the state of Penang, Malaysia.

Authors:  Asrul A Shafie; Mohamed A Hassali
Journal:  Pharm Pract (Granada)       Date:  2010-03-15

4.  Patients' willingness to pay for cognitive pharmacist services in community pharmacies.

Authors:  Dragana Lakić; Ivana Stević; Marina Odalović; Sandra Vezmar-Kovačević; Ivana Tadić
Journal:  Croat Med J       Date:  2017-10-31       Impact factor: 1.351

5.  A Pilot Australian Pharmacist Health Coaching Trial of Participants with Poorly Controlled Hypertension: A Qualitative Study of Participants' and Coaches' Experiences.

Authors:  Harjit Kaur Singh; Gerard Kennedy; Ieva Stupans
Journal:  Patient Prefer Adherence       Date:  2021-01-28       Impact factor: 2.711

6.  Community pharmacists and chronic pain: A qualitative study of experience, perception, and challenges.

Authors:  Hamed Tabeefar; Feng Chang; Martin Cooke; Tejal Patel
Journal:  Can J Pain       Date:  2020-09-24

7.  Patient Satisfaction and Their Willingness to Pay for a Pharmacist Counseling Session in Hospital and Community Pharmacies in Saudi Healthcare Settings.

Authors:  Dhfer Mahdi AlShayban; Atta Abbas Naqvi; Md Ashraful Islam; Mohammed Almaskeen; Ali Almulla; Muhab Alali; Abdullah AlQaroos; Mohamed Raafat; Muhammad Shahid Iqbal; Abdul Haseeb
Journal:  Front Pharmacol       Date:  2020-03-02       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.